WallStreetZenWallStreetZen

NASDAQ: CMPX
Compass Therapeutics Inc Stock Ownership - Who owns Compass Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Compass Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thomas J. SchuetzCHIEF EXECUTIVE OFFICER2025-11-1644,025$4.83
$212.64kSell
Thomas J. SchuetzCHIEF EXECUTIVE OFFICER2025-05-2710,000$2.11
$21.10kBuy
Carl L. GordonDirector2025-04-093,571,428$1.59
$5.68MSell
Orbimed Advisors LLCDirector2025-04-093,571,428$1.59
$5.68MSell
Jonathan AndermanGen Counsel Corporate Sec2025-04-0720,000$1.54
$30.80kBuy
Neil LernerCHIEF ACCOUNTING OFFICER2025-04-0720,000$1.42
$28.40kBuy
Thomas J. SchuetzCEO2025-02-0841,687$3.50
$145.90kSell
Thomas J. SchuetzCEO2025-01-0958,054$1.86
$107.98kSell

1 of 1

CMPX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CMPX insiders and whales buy or sell their stock.

CMPX Shareholders

What type of owners hold Compass Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Tang Capital Management LLC9.45%16,811,963$83.89MInstitution
Carl L. Gordon8.56%15,219,994$75.95MInsider
Orbimed Advisors LLC8.56%15,219,994$75.95MInsider
Orbimed Advisors LLC8.56%15,219,994$75.95MInstitution
Suvretta Capital Management LLC7.93%14,101,159$70.36MInstitution
Blackstone Inc5.53%9,840,108$49.10MInstitution
Vivo Capital LLC5.37%9,545,466$47.63MInstitution
Enavate Sciences GP LLC4.38%7,788,150$38.86MInstitution
Blackrock Inc4.14%7,370,747$36.78MInstitution
Vanguard Group Inc3.97%7,062,799$35.24MInstitution

1 of 3

CMPX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CMPX78.76%21.24%Net SellingNet Selling
MRVI45.43%54.57%Net BuyingNet Buying
YDES0.25%3.67%
AVBP78.59%21.41%Net Buying
MLTX58.60%24.91%Net SellingNet Selling
View Top Biotech Stocks

Compass Therapeutics Stock Ownership FAQ

Who owns Compass Therapeutics?

Compass Therapeutics (NASDAQ: CMPX) is owned by 84.93% institutional shareholders, 22.91% Compass Therapeutics insiders, and 0.00% retail investors. Carl L. Gordon is the largest individual Compass Therapeutics shareholder, owning 15.22M shares representing 8.56% of the company. Carl L. Gordon's Compass Therapeutics shares are currently valued at $75.95M.

If you're new to stock investing, here's how to buy Compass Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.